[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100544817":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":10,"centralContacts":10,"locations":24,"responsibleParty":45,"collaborators":10,"id":47,"slug":48,"hasResults":49,"nctId":50,"briefTitle":51,"officialTitle":51,"acronym":52,"eligibilityCriteria":53,"healthyVolunteers":54,"sex":55,"minAge":56,"maxAge":10,"enrollmentInfo":57,"targetDuration":10,"studyType":60,"phases":10,"briefSummary":61,"conditions":62,"keywords":10,"overallStatus":27,"whyStopped":10,"lastUpdateSubmitDate":64,"lastUpdatePostDateStruct":65,"startDateStruct":68,"completionDateStruct":70,"leadSponsor":72,"locationsCount":73},{"fullName":5,"class":6},"Université Catholique de Louvain","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Control group (N=25)",null,"Female patients visiting the service de Gynécologie of the CUSL for the purpose of intervention in the context of a benign gynecological issue (myomectomy, endometrial resection etc).\n\n* Age ≥ 18 years\n* Pre-menopausal\n* Not HIV or Hepatitis-positive\n* Not having participated in another clinical study in the 12 months prior to recruitment\n* Not presenting symptoms of adenomyosis and\u002For endometriosis",[13],"Diagnostic Test: Circulating-mirna",{"label":15,"type":10,"description":16,"interventionNames":17},"Adenomyosis group (N=25)","Female patients visiting the service de Gynécologie of the CUSL for the purpose of surgical intervention in the context of uterine adenomyosis.\n\n* Age ≥ 18 years\n* Pre-menopausal\n* Not HIV or Hepatitis-positive\n* Not having participated in another clinical study in the 12 months prior to recruitment\n* Not presenting symptoms of endometriosis",[13],[19],{"type":20,"name":21,"description":22,"armGroupLabels":23,"otherNames":10},"DIAGNOSTIC_TEST","Circulating-mirna","A single blood sample (1 tube of 10 ml) on the day of the patient's visit to the service de Gynécologie of the CUSL.",[15,9],[25],{"facility":26,"status":27,"city":28,"state":29,"zip":30,"country":31,"countryCode":32,"cosmosGeoPoint":33,"geoPoint":38,"contacts":39},"CUSL","RECRUITING","Brussels","Woluwe-Saint-Lambert","1200","Belgium","BE",{"type":34,"coordinates":35},"Point",[36,37],4.34878,50.85045,{"lat":37,"lon":36},[40],{"name":41,"role":42,"phone":43,"phoneExt":10,"email":44},"Emilie Wacheul, MD","CONTACT","027645246","emilie.wacheul@uclouvain.be",{"type":46,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100544817","new-perspectives-in-adenomyosis-pathogenesis-with-epigenetic-analysis-and-mirnas-100544817",false,"NCT06373822","New Perspectives in Adenomyosis Pathogenesis With Epigenetic Analysis and miRNAs","ADENO-MIRNA","Inclusion Criteria:\n\n* Age ≥ 18 years\n* Pre-menopausal\n\nExclusion Criteria:\n\n* HIV or Hepatitis-positive\n* having participated in another clinical study in the 12 months prior to recruitment\n* presenting symptoms of endometriosis",true,"FEMALE","18 Years",{"count":58,"type":59},50,"ESTIMATED","OBSERVATIONAL","Objectives:\n\nTo identify differentially expressed miRNAs in the blood of adenomyosis patients in view to develop new diagnostic methods\n\nHypotheses Circulating miRNAs may be abnormally expressed in patients suffering from adenomyosis and could be used to diagnose the disease\n\nStudy Design Blood samples will be collected from healthy subjects and adenomyosis patients and miRNAs will be isolated and analyzed to detect potential differences.",[63],"Adenomyosis","2024-04-18",{"date":66,"type":67},"2024-04-22","ACTUAL",{"date":69,"type":67},"2024-03-21",{"date":71,"type":59},"2031-09",{"name":5,"class":6},1]